Related Experiment Video
Updated: Feb 27, 2026
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.5K
Cellular reprogramming technology for dissecting cancer epigenome in vivo
1Center for iPS Cell Research & Application, Kyoto University, Kyoto 606-8507, Japan.
Epigenomics
|June 28, 2017
Summary
Epigenetic abnormalities can directly cause cancer development, not just result from genetic mutations. Recent studies using reprogramming technologies confirm their significant role in cancer initiation, maintenance, and progression.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic alterations are implicated in cancer development.
- Genetic mutations in epigenetic modifiers may cause epigenetic changes, obscuring their causal role.
- The independent causal role of epigenetic abnormalities in cancer remains unclear.
Purpose of the Study:
- To investigate the causal role of epigenetic abnormalities in cancer development.
- To leverage reprogramming technologies to study epigenetic impacts on cancer.
- To provide in vivo evidence for epigenetic abnormalities' role in cancer.
Main Methods:
- Utilizing reprogramming technologies to alter epigenetic regulations.
- Preserving genomic information during epigenetic manipulation.
- Conducting in vivo studies to assess epigenetic impacts.
Main Results:
- Recent studies provide in vivo evidence for epigenetic abnormalities' significant impact.
- Epigenetic alterations are shown to influence cancer initiation.
- Epigenetic abnormalities are crucial for cancer maintenance and progression.
Conclusions:
- Bona fide epigenetic abnormalities have a causal role in cancer development.
- Reprogramming technologies are valuable tools for studying epigenetic roles in cancer.
- Epigenetic dysregulation is a key driver in cancer initiation, maintenance, and progression.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:14Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
01:37Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
01:32Chromatin Modification in iPS Cells
2.2K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K